Analysis of a Novel pncA Mutation for Susceptibility to Pyrazinamide Therapy. (2018)
Attributed to:
Newton001 Understanding Antimicrobial Resistance Mutations in Tuberculosis: Towards Personalised Treatment to Combat Multi-drug Resistance
funded by
Newton Fund
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1164/rccm.201712-2572le
PubMed Identifier: 29694240
Publication URI: http://europepmc.org/abstract/MED/29694240
Type: Journal Article/Review
Volume: 198
Parent Publication: American journal of respiratory and critical care medicine
Issue: 4
ISSN: 1073-449X